Market Tracker

05/27 5:16pm ET

Aviragen Therapeutics Inc (NASDAQ:AVIR)

1.45
Delayed Data
As of May 27
 -0.14 / -8.81%
Today’s Change
1.23
Today|||52-Week Range
2.66
-25.26%
Year-to-Date
No recent news for Aviragen Therapeutics Inc.

Today’s Trading

Previous close1.59
Today’s open1.48
Day’s range1.43 - 1.53
Volume120,437
Average volume (3 months)37,010
Market cap$56.0M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-54.29%
Earnings growth (this year)+59.26%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-64.19%
P/E ratioNM
Price/Sales2.98
Price/Book0.81

Competitors

 Today’s
change
Today’s
% change
MTEXMannatech Inc-0.10-0.48%
AVEOAveo Pharmaceuticals...+0.02+2.17%
BLRXBioLine RX Ltd+0.05+5.42%
AKAOAchaogen Inc+0.32+11.35%
Data as of 3:59pm ET, 05/27/2016

Financials

Next reporting dateSeptember 9, 2016
EPS forecast (this quarter)-$0.18
Annual revenue (last year)$24.6M
Annual profit (last year)-$19.1M
Net profit margin-77.64%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Joseph M. Patti
Chief Financial Officer &
Executive Vice President
Mark P. Colonnese
Corporate headquarters
Alpharetta, Georgia

Forecasts